Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check3 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.3%
- Check10 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference1%
- Check17 days agoChange DetectedDifference0.7%
- Check24 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check31 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.3, replacing the previous version v2.16.2. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.0%
- Check39 days agoChange DetectedThe page has been updated with new dates for clinical trial milestones and revisions to the informed consent form, indicating a shift in the timeline and documentation related to the study.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.